Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer. (November 2022)

Record Type:: Journal Article
Title:: Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer. (November 2022)
Main Title:: Development of antibody-drug conjugates targeting the CDCP1 receptor for the treatment of Triple negative and metastatic breast cancer
Authors:: Gough, M.
Kwah, K.
Khan, T.
He, Y.
Pyke, C.
Ratnayake, G.
Snell, C.
Hooper, J.
Kryza, T.
Abstract:
Is Part Of:: European journal of cancer. Volume 175(2022)Supplement 1
Journal:: European journal of cancer
Issue:: Volume 175(2022)Supplement 1
Issue Display:: Volume 175, Issue 1 (2022)
Year:: 2022
Volume:: 175
Issue:: 1
Issue Sort Value:: 2022-0175-0001-0000
Page Start:: S81
Page End:: S82
Publication Date:: 2022-11
Subjects:: Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994
Journal URLs:: http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/S0959-8049(22)01571-4 ↗
Languages:: English
ISSNs:: 0959-8049
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store
Ingest File:: 24406.xml